Skip to Main Content

Author Details

Leigh C Carmody
Center for the Science of Therapeutics, Broad Institute of MIT and Harvard
2002
33
18
PMIDPaper TitleJournal TitlePublished Year
37684057De novo <i>TRPM3</i> missense variant associated with neurodevelopmental delay and manifestations of cerebral palsy.Cold Spring Harb Mol Case Stud2024
37953324The Human Phenotype Ontology in 2024: phenotypes around the world.Nucleic Acids Res2024
37684057De novo <i>TRPM3</i> missense variant associated with neurodevelopmental delay and manifestations of cerebral palsy.Cold Spring Harb Mol Case Stud2024
37953324The Human Phenotype Ontology in 2024: phenotypes around the world.Nucleic Acids Res2024
36929917An expectation-maximization framework for comprehensive prediction of isoform-specific functions.Bioinformatics2023
37963467The Medical Action Ontology: A tool for annotating and analyzing treatments and clinical management of human disease.Med2023
37196000Phenopacket-tools: Building and validating GA4GH Phenopackets.PLoS One2023
36929917An expectation-maximization framework for comprehensive prediction of isoform-specific functions.Bioinformatics2023
37503136The Medical Action Ontology: A Tool for Annotating and Analyzing Treatments and Clinical Management of Human Disease.medRxiv2023
37963467The Medical Action Ontology: A tool for annotating and analyzing treatments and clinical management of human disease.Med2023
37503136The Medical Action Ontology: A Tool for Annotating and Analyzing Treatments and Clinical Management of Human Disease.medRxiv2023
37196000Phenopacket-tools: Building and validating GA4GH Phenopackets.PLoS One2023
35101336Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).Genet Med2022
35872606Prenatal phenotyping: A community effort to enhance the Human Phenotype Ontology.Am J Med Genet C Semin Med Genet2022
36063163Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).Genet Med2022
37324543A community effort for COVID-19 Ontology Harmonization.CEUR Workshop Proc2022
35101336Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).Genet Med2022
37324543A community effort for COVID-19 Ontology Harmonization.CEUR Workshop Proc2022
35872606Prenatal phenotyping: A community effort to enhance the Human Phenotype Ontology.Am J Med Genet C Semin Med Genet2022
36063163Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).Genet Med2022
33264411The Human Phenotype Ontology in 2021.Nucleic Acids Res2021
33752678Correction to: A guide to writing systematic reviews of rare disease treatments to generate FAIRcompliant datasets: building a Treatabolome.Orphanet J Rare Dis2021
34289339Interpretable prioritization of splice variants in diagnostic next-generation sequencing.Am J Hum Genet2021
33264411The Human Phenotype Ontology in 2021.Nucleic Acids Res2021
34739835Interpretable prioritization of splice variants in diagnostic next-generation sequencing.Am J Hum Genet2021
33752678Correction to: A guide to writing systematic reviews of rare disease treatments to generate FAIRcompliant datasets: building a Treatabolome.Orphanet J Rare Dis2021
34739835Interpretable prioritization of splice variants in diagnostic next-generation sequencing.Am J Hum Genet2021
34289339Interpretable prioritization of splice variants in diagnostic next-generation sequencing.Am J Hum Genet2021
32755546Interpretable Clinical Genomics with a Likelihood Ratio Paradigm.Am J Hum Genet2020
32019583Significantly different clinical phenotypes associated with mutations in synthesis and transamidase+remodeling glycosylphosphatidylinositol (GPI)-anchor biosynthesis genes.Orphanet J Rare Dis2020
32755546Interpretable Clinical Genomics with a Likelihood Ratio Paradigm.Am J Hum Genet2020
32787960A guide to writing systematic reviews of rare disease treatments to generate FAIR-compliant datasets: building a Treatabolome.Orphanet J Rare Dis2020
32019583Significantly different clinical phenotypes associated with mutations in synthesis and transamidase+remodeling glycosylphosphatidylinositol (GPI)-anchor biosynthesis genes.Orphanet J Rare Dis2020
32787960A guide to writing systematic reviews of rare disease treatments to generate FAIR-compliant datasets: building a Treatabolome.Orphanet J Rare Dis2020
30476213Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources.Nucleic Acids Res2019
30476213Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources.Nucleic Acids Res2019
31479590Encoding Clinical Data with the Human Phenotype Ontology for Computational Differential Diagnostics.Curr Protoc Hum Genet2019
31479590Encoding Clinical Data with the Human Phenotype Ontology for Computational Differential Diagnostics.Curr Protoc Hum Genet2019
29632381Plain-language medical vocabulary for precision diagnosis.Nat Genet2018
29632381Plain-language medical vocabulary for precision diagnosis.Nat Genet2018
25660025Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic Progenitors.Cell Rep2015
25660025Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic Progenitors.Cell Rep2015
23403082Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.Bioorg Med Chem Lett2013
23403082Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.Bioorg Med Chem Lett2013
24900788Diversity-oriented synthesis yields a new drug lead for treatment of chagas disease.ACS Med Chem Lett2013
24900788Diversity-oriented synthesis yields a new drug lead for treatment of chagas disease.ACS Med Chem Lett2013
22503247Identification of a selective small molecule inhibitor of breast cancer stem cells.Bioorg Med Chem Lett2012
22853929Screening for inhibitors of an essential chromatin remodeler in mouse embryonic stem cells by monitoring transcriptional regulation.J Biomol Screen2012
22503247Identification of a selective small molecule inhibitor of breast cancer stem cells.Bioorg Med Chem Lett2012
22941295Phenotypic high-throughput screening elucidates target pathway in breast cancer stem cell-like cells.J Biomol Screen2012
  • 1 - 50 of 66

Recommended Authors

Icahn School of Medicine at Mount Sinai
Career Start Year 2011
Number of shared co-authors 6
Medical College of Wisconsin
Career Start Year 2009
Number of shared co-authors 10
University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 1
Institute for Systems Biology
Career Start Year 2007
Number of shared co-authors 0
School of Public Health, Imperial College London
Career Start Year 2006
Number of shared co-authors 1
Institute for Next Generation Healthcare
Career Start Year 2006
Number of shared co-authors 2
University of Bristol
Career Start Year 2006
Number of shared co-authors 5
The Wellcome Sanger Institute
Career Start Year 2005
Number of shared co-authors 3
Icahn School of Medicine at Mount Sinai
Career Start Year 2005
Number of shared co-authors 3
University of Zurich
Career Start Year 2005
Number of shared co-authors 1
Universitatsklinikum
Career Start Year 2003
Number of shared co-authors 2
University of Colorado Anschutz Medical Campus
Career Start Year 2003
Number of shared co-authors 42
Children's Hospital of Philadelphia
Career Start Year 2003
Number of shared co-authors 2
Schroeder Arthritis Institute
Career Start Year 2002
Number of shared co-authors 1
The Scripps Research Institute
Career Start Year 2001
Number of shared co-authors 13
University of Washington
Career Start Year 2001
Number of shared co-authors 14
Mayo Clinic College of Medicine and Science
Career Start Year 2001
Number of shared co-authors 14
Johns Hopkins University School of Medicine
Career Start Year 2000
Number of shared co-authors 5
The Ohio State University
Career Start Year 2000
Number of shared co-authors 10
University of Toronto
Career Start Year 2000
Number of shared co-authors 9
Schroeder Arthritis Institute
Career Start Year 1998
Number of shared co-authors 3
The University of Queensland Diamantina Institute, The University of Queensland
Career Start Year 1997
Number of shared co-authors 0
William Harvey Research Institute, Queen Mary University of London
Career Start Year 1997
Number of shared co-authors 12
Oregon Health & Science University, University of California Berkeley
Career Start Year 1997
Number of shared co-authors 1
University of Michigan Medical School ann arbor
Career Start Year 1996
Number of shared co-authors 1
St. George's University Medical School
Career Start Year 1990
Number of shared co-authors 24
Yale School of Medicine
Career Start Year 1989
Number of shared co-authors 11
Stanford University
Career Start Year 1982
Number of shared co-authors 7
University of Michigan Medical School ann arbor
Career Start Year 1977
Number of shared co-authors 6
Center for Biomedical Informatics and Biostatistics, University of Arizona
Career Start Year 1971
Number of shared co-authors 2

Collaborators

American Medical Informatics Association, Oregon Health and Science University, Oregon State University, University of Colorado Anschutz Medical Campus, University of North Carolina at Chapel Hill, University of Wisconsin-Madison
Co-authored papers 12
William Harvey Research Institute, Queen Mary University of London
Co-authored papers 12
Co-authored papers 11
Co-authored papers 10
Critical Path Institute
Co-authored papers 9
Biomedical Research Center, Slovak Academy of Sciences
Co-authored papers 9
International Society for Biocuration, Lawrence Berkeley National Laboratory, University of Edinburgh, University of Edinburgh School of Biological Sciences
Co-authored papers 9
University of Colorado - Anschutz Medical Campus
Co-authored papers 8
William Harvey Research Institute, Queen Mary University of London
Co-authored papers 7
Co-authored papers 6
William Harvey Research Institute, Queen Mary University of London
Co-authored papers 6
Children's Hospital of Eastern Ontario Research Institute
Co-authored papers 5
Perth Children's Hospital
Co-authored papers 5
Division of Emergency Medicine University of Calgary Calgary Alberta Canada.
Co-authored papers 5
Vall d'Hebron University Hospital and VHIR (Euro-NMD
Co-authored papers 5
Children's Hospital of Eastern Ontario Research Institute
Co-authored papers 5
Broad Institute
Co-authored papers 5
University of Colorado Anschutz Medical Campus
Co-authored papers 4
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 4
University of Colorado Anschutz Medical Campus
Co-authored papers 4
Translational and Clinical Research Institute, Newcastle University
Co-authored papers 4
DOE Joint Genome Institute, Lawrence Berkeley National Laboratory
Co-authored papers 4
Lawrence Berkely National Laboratory, Massachusetts Institute of Technology, Princeton University
Co-authored papers 4
Universitatsklinikum des Saarlandes UKS
Co-authored papers 4
Oregon Health & Science University
Co-authored papers 3
Co-authored papers 3
INSERM
Co-authored papers 3
Hospital Universitari Vall d'Hebron
Co-authored papers 3
King Edward Memorial Hospital
Co-authored papers 3
University of Colorado Anschutz Medical Campus
Co-authored papers 3